Close Menu

Alfa Wassermann has named Mark Flocco and Dino DiCamillo as vice president and president, respectively, to its proteomic technologies division, Alfa Wassermann Proteomic Technologies.

DiCamillo comes to Alfa Wassermann from Invitrogen, where he was vice president of environmental diagnostics and commercial operations. Prior to that, he was president of Dynal Biotech, spent 13 years with Applied Biosystems, and has worked for Nicolet Instruments and Bio-Rad Laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.